Marshall Wace’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-438,617
| Closed | -$2.93M | – | 2912 |
|
|
2025
Q1 | $2.93M | Sell |
438,617
-18,145
| -4% | -$121K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $5.74M | Buy |
456,762
+446,662
| +4,422% | +$5.61M | 0.01% | 924 |
|
|
2024
Q3 | $187K | Sell |
10,100
-9,483
| -48% | -$175K | ﹤0.01% | 2138 |
|
|
2024
Q2 | $422K | Buy |
+19,583
| New | +$422K | ﹤0.01% | 1840 |
|
|
2023
Q1 | – | Sell |
-13,500
| Closed | -$264K | – | 2518 |
|
|
2022
Q4 | $264K | Sell |
13,500
-88,356
| -87% | -$1.73M | ﹤0.01% | 2020 |
|
|
2022
Q3 | $1.63M | Buy |
101,856
+88,056
| +638% | +$1.41M | ﹤0.01% | 1633 |
|
|
2022
Q2 | $190K | Buy |
+13,800
| New | +$190K | ﹤0.01% | 2472 |
|
|
2022
Q1 | – | Sell |
-95,569
| Closed | -$2.09M | – | 3185 |
|
|
2021
Q4 | $2.09M | Buy |
+95,569
| New | +$2.09M | ﹤0.01% | 1600 |
|
|
2021
Q1 | – | Sell |
-35,390
| Closed | -$1.94M | – | 2447 |
|
|
2020
Q4 | $1.94M | Buy |
+35,390
| New | +$1.94M | 0.01% | 873 |
|
|
2020
Q1 | – | Sell |
-3,877
| Closed | -$88K | – | 1952 |
|
|
2019
Q4 | $88K | Buy |
3,877
+2,573
| +197% | +$58.4K | ﹤0.01% | 1424 |
|
|
2019
Q3 | $15K | Sell |
1,304
-130,444
| -99% | -$1.5M | ﹤0.01% | 1564 |
|
|
2019
Q2 | $1.98M | Sell |
131,748
-14,244
| -10% | -$214K | 0.02% | 748 |
|
|
2019
Q1 | $2.56M | Buy |
+145,992
| New | +$2.56M | 0.02% | 659 |
|